UC Looks for Payoffs from Weapons Labs

LIVERMORE, CALIF.—The University of California will continue to run the nation’s two federal laboratories for designing nuclear weapons, with a new five-year contract that nearly doubles its management fee. Officials said that much of the extra money will be spent on commercializing research from the federal labs. The regents voted 17-3, with one abstention, to maintain the university’s ties to the Lawrence Livermore National Laboratory in Livermore, Calif., and the Los Ala

Written byVincent Kiernan
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

LIVERMORE, CALIF.—The University of California will continue to run the nation’s two federal laboratories for designing nuclear weapons, with a new five-year contract that nearly doubles its management fee. Officials said that much of the extra money will be spent on commercializing research from the federal labs.

The regents voted 17-3, with one abstention, to maintain the university’s ties to the Lawrence Livermore National Laboratory in Livermore, Calif., and the Los Alamos National Laboratory in Los Alamos, N.M. The U.S. Energy Department owns both facilities, but lab workers are university employees.

The regents also voted to renew their contract for a third Energy Department facility, the Lawrence Berkeley Laboratory in Berkeley, Calif. That lab focuses on basic re search and does no classified work. In return for operating the three labs—which together employ about 9,000 people and have a combined budget of $1.9 billion—the university will receive $62.5 million over ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies